Hi Wayne, I stopped following this stock when they had the difficulties with the IV version been up taken by the liver before it got to the tissues and then they started developing the inhaled version. In that time. Why have they gone back to the IV version one? It's still be uptaken by the liver too much. What has happened in the past 1 to 2 years in this company? Thanks
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.142M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $7.077K | 3.538M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 19342107 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 5092565 | 13 |
View Market Depth
| Last trade - 13.48pm 20/06/2025 (20 minute delay) ? |
| 1AD (ASX) Chart |